tiprankstipranks
Zenas BioPharma, Inc. (ZBIO)
NASDAQ:ZBIO
US Market

Zenas BioPharma, Inc. (ZBIO) Stock Investors

Compare
67 Followers
Based on 788,370 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ZBIO
On average, investors allocate 0.00% of their portfolios to ZBIO
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 788,370 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ZBIO

1.8%
Last 7
Days
6.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ZBIO, out of 788,370 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ZBIO Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
1.69%
$7.92
Based on the activity of investors who made their portfolios public
The table shows changes in ZBIO in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ZBIO Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.90%
-0.95%
+1.82%
3.52B
Healthcare
Devon Energy
4.11%
+2.89%
+1.44%
25.02B
Energy
Oklo Inc
4.39%
+0.09%
+17.75%
5.21B
Financial
Fortinet
3.70%
+1.12%
+8.24%
87.54B
Technology
Plug Power
5.01%
-1.28%
-2.16%
1.63B
Industrials
Lucid Group
5.55%
-0.27%
+0.42%
9.97B
Consumer Cyclical
RTX
3.66%
+0.71%
+11.31%
166.66B
Industrials
Intuit
2.88%
-1.26%
-2.75%
162.09B
Technology
Lockheed Martin
4.53%
-0.29%
+5.31%
102.70B
Industrials
Lululemon Athletica
4.43%
-0.66%
-1.00%
46.42B
Consumer Cyclical
Based on the activity of 788,370 active portfolios
Open your Smart Portfolio

ZBIO Investor Analysis

ZBIO investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
25.0%
of ZBIO holders
are under 35
Average Segment Performance
Average P/E Ratio39.08
Beta11.18
Dividend Yield3.84%
ZBIO investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
50.0%
of ZBIO holders
are between 35–55
Average Segment Performance
Average P/E Ratio37.72
Beta20.89
Dividend Yield3.28%
ZBIO investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
25.0%
of ZBIO holders
are over 55
Average Segment Performance
Average P/E Ratio36.08
Beta10.18
Dividend Yield3.48%
Overview of age group and performance of ZBIO stock investors
See who invests in ZBIO according to age group and performance.

FAQ

How many retail Investors hold ZBIO?
<0.1% of TipRanks' retail investors hold ZBIO in their portfolios.
    What is ZBIO Investor Sentiment?
    ZBIO’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of ZBIO in the last 7 days?
      ▼ 1.8% of TipRanks' retail investors changed their holding of ZBIO in the last 7 days.
        What percentage of retail investors changed their holding of ZBIO in the last 30 days?
        ▲ 6.6% of TipRanks' retail investors changed their holding of ZBIO in the last 30 days.
          What is the average age of retail investors who hold ZBIO?
          The average age of ZBIO Holders is between 35–55.
            What other stocks have ZBIO investors also bought?
            ZBIO Investors also bought VKTX, DVN, OKLO, FTNT, PLUG, LCID, RTX, INTU, LMT, LULU.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALKSAlkermes
              BDXBecton Dickinson
              CNCCentene
              CHRSCoherus Biosciences
              CICigna
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis